Lhyfe S.A.S [LHYFE] vs Arkema S.A [AKE] Detailed Stock Comparison

Lhyfe S.A.S.

EURONEXT
Loading...

Arkema S.A.

EURONEXT
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Lhyfe S.A.S. wins in 1 metrics, Arkema S.A. wins in 16 metrics, with 0 ties. Arkema S.A. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Lhyfe S.A.S. Arkema S.A. Better
P/E Ratio (TTM) -3.85 121.37 Arkema S.A.
Price-to-Book Ratio 5.11 0.77 Arkema S.A.
Debt-to-Equity Ratio 563.47 64.82 Arkema S.A.
PEG Ratio -7.26 10.63 Arkema S.A.
EV/EBITDA -5.09 6.34 Arkema S.A.
Profit Margin (TTM) 82.53% 0.70% Lhyfe S.A.S.
Operating Margin (TTM) -400.86% 4.37% Arkema S.A.
EBITDA Margin (TTM) N/A 4.37% N/A
Return on Equity -109.42% 0.84% Arkema S.A.
Return on Assets (TTM) -10.25% 1.72% Arkema S.A.
Free Cash Flow (TTM) $-62.04M $337.00M Arkema S.A.
1-Year Return -30.00% -3.18% Arkema S.A.
Price-to-Sales Ratio (TTM) 11.37 0.52 Arkema S.A.
Enterprise Value $157.12M $7.24B Arkema S.A.
EV/Revenue Ratio 16.08 0.80 Arkema S.A.
Revenue per Share (TTM) $0 $120 Arkema S.A.
Earnings per Share (Diluted) $-0.77 $0.51 Arkema S.A.
Beta (Stock Volatility) 1.05 0.95 Arkema S.A.

Lhyfe S.A.S. vs Arkema S.A. Stock Performance Analysis

Loading Price Chart...

LHYFE
AKE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Lhyfe S.A.S.-1.55%-3.83%-4.24%-8.50%-24.41%-20.70%
Arkema S.A.2.60%3.54%-0.81%5.86%18.51%17.38%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Lhyfe S.A.S.-30.00%-67.00%-73.26%-73.26%-73.26%-73.26%
Arkema S.A.-3.18%-28.92%-44.08%-17.09%7.58%7.58%

Performance & Financial Health Analysis: Lhyfe S.A.S. vs Arkema S.A.

MetricLHYFEAKE
Market Information
Market Cap i€112.97M€4.67B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i26,673225,846
90 Day Avg. Volume i38,268314,292
Last Close€2.22€63.05
52 Week Range€2.17 - €3.62€48.30 - €67.05
% from 52W High-38.59%-5.97%
All-Time High€9.50 (Oct 24, 2022)€134.95 (Jan 17, 2022)
% from All-Time High-76.63%-53.28%
Growth Metrics
Quarterly Revenue Growth0.50%-0.07%
Quarterly Earnings GrowthN/A-0.07%
Financial Health
Profit Margin (TTM) i0.83%0.01%
Operating Margin (TTM) i-4.01%0.04%
Return on Equity (TTM) i-1.09%0.01%
Debt to Equity (MRQ) i563.4764.82
Cash & Liquidity
Book Value per Share (MRQ)€0.45€79.90
Cash per Share (MRQ)€1.55€28.93
Operating Cash Flow (TTM) i€-21,882,000€997.00M
Levered Free Cash Flow (TTM) i€-35,079,000€660.00M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Lhyfe S.A.S. vs Arkema S.A.

MetricLHYFE (Apr 24, 2026)AKE (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-3.85121.37
Forward P/E i-7.2610.63
PEG Ratio i-7.2610.63
Price to Sales (TTM) i11.370.52
Price to Book (MRQ) i5.110.77
Market Capitalization
Market Capitalization i€112.97M€4.67B
Enterprise Value i€157.12M€7.24B
Enterprise Value Metrics
Enterprise to Revenue i16.080.80
Enterprise to EBITDA i-5.096.34
Risk & Other Metrics
Beta i1.050.95
Book Value per Share (MRQ) i€0.45€79.90

Financial Statements Comparison: Lhyfe S.A.S. vs Arkema S.A.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLHYFE (2024)AKE (2025)
Revenue/Sales i5.10M9.07B
Cost of Goods Sold i891,0007.45B
COGS % of Revenue i17.5%82.2%
Gross Profit i4.21M1.61B
Gross Margin i82.5%17.8%
Research & Development iN/A284.00M
Operating Income (EBIT) i-28.11M420.00M
Operating Margin i-551.2%4.6%
EBITDA i-21.08M1.24B
EBITDA Margin i-413.4%13.7%
Pre-Tax Income i-27.80M162.00M
Pre-Tax Income % of Revenue i-545.1%1.8%
Income Tax i0100.00M
Income Tax % of Revenue i0.0%1.1%
Net Income (Profit) i-29.19M62.00M
Profit Margin i-572.4%0.7%

Balance Sheet & Liquidity Metrics

MetricLHYFE (2024)AKE (2025)
Cash & Equivalents i72.12M2.19B
Total Current Assets i95.84M4.83B
Total Current Assets % of Revenue i1,879.7%53.2%
Total Current Liabilities i51.42M2.26B
Total Current Liabilities % of Revenue i1,008.5%24.9%
Long-Term Debt i71.04M3.80B
Long-Term Debt % of Revenue i1,393.2%41.9%
Total Shareholders Equity i71.68M7.03B
Retained Earnings i-29.09M4.38B
Retained Earnings % of Revenue i-570.5%48.2%
Property, Plant & Equipment i40.26M1.25B

Cash Flow Statement Comparison

MetricLHYFE (2024)AKE (2025)
Operating Cash Flow i-34.61M62.00M
Operating Cash Flow % of Revenue i-678.7%0.7%
Capital Expenditures i-27.08M-24.00M
Free Cash Flow i-62.04M337.00M
FCF Margin i-1,216.8%3.7%
Debt Repayment i-2.27M-448.00M
Common Stock Repurchase iN/A-33.00M

Short Interest & Institutional Ownership Analysis

MetricLHYFEAKE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i47.92M75.64M
Float Shares i16.46M56.93M
% Held by Insiders i60.48%10.31%
% Held by Institutions i8.08%58.95%
% Held by Public i31.44%30.74%

Dividend Analysis & Yield Comparison: Lhyfe S.A.S. vs Arkema S.A.

MetricLHYFEAKE
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A